retatrutide clinical trial results 2025 New Obesity Drug Helped People Lose Nearly One-Third Their Body Weight Results from retatrutide clinical trials?

Additionally, both semaglutide and tirzepatide showed promise in improving metabolic dysfunction-associated steatotic liver disease (MASLD), mitigating systemic inflammation, and contributing to improvements in liver-related outcomes, including steatosis resolution and fibrosis-related endpoints, in clinical trials

Potential Benefits: Promotes Longevity: By maintaining the integrity of DNA through telomere elongation, Epithalon can contribute to longer life expectancy

Eleven states covered all three GLP-1s approved for obesity treatment

Two to three strength sessions weekly, focusing on major muscle groups, preserves and even builds lean mass during weight loss